Richard Case wrote:
> As a rather "silent" member of the list, the topic of "Skin cancer & PD"
> woke me up! I have had parkinson for over 10 years and am currently
> battling reoccurring skin cancer.
> My question to the list is -- Is there any published or medical
> information on the effect of parkinson's or it's medication on skin
> cancer?
> Yola Case 48/10

Dear Yola,
I've been concerned about this, too, and am also searching for
information. Here is a list of articles that have been written on the
subject; to search for yourself, go to Medline:
http://www4.ncbi.nlm.nih.gov/PubMed/

and enter:
parkinson's disease and skin cancer

Best,
Kathrynne
=====================================


23 citations found

          for the articles selected (default all).
       documents on this page through Loansome Doc

    Rampen F.           [See Related Articles]
     Melanoma and levodopa.
     J Am Acad Dermatol. 1998 May;38(5 Pt 1):782-4. No abstract
available.
     PMID: 9591833; UI: 98252530.

    Pfutzner W, et al.           [See Related Articles]
     Malignant melanoma and levodopa: is there a relationship? Two new
cases and a review of the literature.
     J Am Acad Dermatol. 1997 Aug;37(2 Pt 2):332-6. Review.
     PMID: 9270541; UI: 97416591.

    Kleinhans M, et al.           [See Related Articles]
     [Levodopa and malignant melanoma--case report and review of the
literature. A contribution to causal relationship
     between levodopa and the development of malignant melanoma].
     Hautarzt. 1996 Jun;47(6):432-7. Review. German.
     PMID: 8767657; UI: 96293932.

    Maffioli L, et al.           [See Related Articles]
     Scintigraphic detection of melanoma metastases with a radiolabeled
benzamide ([iodine-123]-(S)-IBZM).
     J Nucl Med. 1994 Nov;35(11):1741-7.
     PMID: 7965150; UI: 95054473.

    Weiner WJ, et al.           [See Related Articles]
     Levodopa, melanoma, and Parkinson's disease.
     Neurology. 1993 Apr;43(4):674-7. Review.
     PMID: 8469320; UI: 93226097.

    Merello M, et al.           [See Related Articles]
     Impaired levodopa response in Parkinson's disease during melanoma
therapy.
     Clin Neuropharmacol. 1992 Feb;15(1):69-74.
     PMID: 1576600; UI: 92248572.

    Kande'l EI.           [See Related Articles]
     [Melanoma as a possible complication of the treatment of
parkinsonism with L-dopa preparations].
     Zh Nevropatol Psikhiatr. 1989;89(9):126-7. Review. Russian. No
abstract available.
     PMID: 2692357; UI: 90118487.

    Foster HD.           [See Related Articles]
     Disease family trees: the possible roles of iodine in goitre,
cretinism, multiple sclerosis, amyotrophic lateral sclerosis,
     Alzheimer's and Parkinson's diseases and cancers of the thyroid,
nervous system and skin.
     Med Hypotheses. 1987 Nov;24(3):249-63. Review.
     PMID: 3320695; UI: 88093887.

    Kochar AS.           [See Related Articles]
     Development of malignant melanoma after levodopa therapy for
Parkinson's disease. Report of a case and review of the
     literature.
     Am J Med. 1985 Jul;79(1):119-21.
     PMID: 4014296; UI: 85248585.

    Ostrovskii MA, et al.           [See Related Articles]
     [Physiologic functions of melanin in the body].
     Fiziol Cheloveka. 1985 Jul-Aug;11(4):670-8. Review. Russian. No
abstract available.
     PMID: 3899834; UI: 86006072.

    Rampen FH.           [See Related Articles]
     Levodopa and melanoma: three cases and review of literature.
     J Neurol Neurosurg Psychiatry. 1985 Jun;48(6):585-8.
     PMID: 4009196; UI: 85236384.

    Rosin MA, et al.           [See Related Articles]
     Malignant melanoma and levodopa.
     Cutis. 1984 Jun;33(6):572-4.
     PMID: 6744949; UI: 84260720.

    Stewart RM, et al.           [See Related Articles]
     Urinary 5-S-cysteinyldopa in Parkinsonism after DOPA and carbidopa.
     Acta Derm Venereol. 1983;63(2):97-101.
     PMID: 6189350; UI: 83200071.

    Bernstein JE, et al.           [See Related Articles]
     Levodopa administration and multiple primary cutaneous melanomas.
     Arch Dermatol. 1980 Sep;116(9):1041-44.
     PMID: 7416757; UI: 81020152.

    Fermaglich J, et al.           [See Related Articles]
     Levodopa and melanoma.
     JAMA. 1979 Mar 2;241(9):883-4. No abstract available.
     PMID: 762862; UI: 79112202.

    Sober AJ, et al.           [See Related Articles]
     Levodopa therapy and malignant melanoma.
     JAMA. 1978 Aug 11;240(6):554-5.
     PMID: 671667; UI: 78220960.

    Fermaglich J, et al.           [See Related Articles]
     Parkinson's disease, melanoma, and levodopa.
     J Neurol. 1977 Jun 13;215(3):221-4. No abstract available.
     PMID: 69691; UI: 77229688.

    Pelfrene AF.           [See Related Articles]
     [Letter: Malignant melanoma during treatment with levodopa].
     Nouv Presse Med. 1975 May 3;4(18):1365. French. No abstract
available.
     PMID: 1153302; UI: 75217515.

    Happle.           [See Related Articles]
     [Malignant melanoma and L-dopa. Review of literature on the problem
of causal relationship].
     Fortschr Med. 1974 Sep 26;92(27):1065-6. German. No abstract
available.
     PMID: 4457419; UI: 75132192.

    Lieberman AN, et al.           [See Related Articles]
     Levodopa and melanoma.
     Neurology. 1974 Apr;24(4):340-3. No abstract available.
     PMID: 4856355; UI: 74127320.

    Robinson E, et al.           [See Related Articles]
     Levodopa and malignant melanoma.
     Arch Pathol. 1973 Mar;95(3):213. No abstract available.
     PMID: 4686512; UI: 73095507.

    Skibba JL, et al.           [See Related Articles]
     Multiple primary melanoma following administration of levodopa.
     Arch Pathol. 1972 Jun;93(6):556-61. No abstract available.
     PMID: 5025039; UI: 72181169.

    Cisneros Vela JL, et al.           [See Related Articles]
     [Familial basal cell nevus syndrome].
     Actas Dermosifiliogr. 1968 Sep-Oct;59(9):533-48. Spanish. No
abstract available.
     PMID: 5747297; UI: 70267439.

--
Kathrynne Holden, MS, RD
"Nutrition you can live with!"
Medical nutrition therapy
http://www.nutritionucanlivewith.com/
Tel: 970-493-6532 // Fax: 970-493-6538
"If we knew what it was we were doing,
it would not be called research,
would it?" -Albert Einstein